Kumdee, C., Yadee, J., Pantumongkol, W., Hadnorntun, P., Kittiratchakul, N., Leelahavarong, P., Suchonwanich, N., & Ekakkararungroj, C. (2021). Consequences and Enablers of the Selection of High-Cost Medicines to the National List of Essential Medicines Category E(2). Journal of Health Systems Research, 15(4), 456–476. retrieved from https://he04.tci-thaijo.org/index.php/j_hsr/article/view/3300